Synageva BioPharma To Present At The Nomura Biotechnology Conference
Published: Feb 10, 2014
LEXINGTON, Mass., Oct. 29, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced today that Sanj K. Patel, President and Chief Executive Officer of Synageva, will present at the Nomura Biotechnology Conference in Boston, MA on Thursday, November 6, 2014, at 8:00 a.m. EST. The presentation will be webcast live and may be accessed from the "Webcasts & Presentations" section of the Investor Relations tab on the home page of Synageva's website at www.synageva.com.
Synageva routinely posts information that may be important to investors in the "Investor Relations" section of the company's website at www.synageva.com. Synageva encourages investors and potential investors to consult this website regularly for important information about the company.
Further information regarding Synageva BioPharma Corp. is available at www.synageva.com.
"Synageva BioPharma" is a trademark, and "Dedicated to Rare Diseases" is a registered trademark, of Synageva.
SOURCE Synageva BioPharma Corp.